Of these, CD206+, CD204+ and CD163+ Mφs are suggested to represent immunosuppressive Mφs that promote tumor progression, whereas CD169+ Mφs display antitumor properties in HCC (18–20). Here, SIGLEC1 is linked to hepatocellular carcinoma.